Non-alcoholic Steatohepatitis-related Liver Cirrhosis is Increasing in China: a Ten-year Retrospective Study

Overview

Journal Clinics (Sao Paulo)

Publisher Elsevier

Specialty General Medicine

Date 2015 Aug 7

PMID 26247669

Citations 10

Authors

Ji Xiong

Juan Huang

Wenjing Sun

Jun Wang

Dongfeng Chen

Affiliations

Soon will be listed here.

Abstract

Objective: Little is known about metabolic factors in cirrhotic patients in China. Therefore, we aimed to quantify the prevalence of both metabolic factors and non-alcoholic steatohepatitis-related liver cirrhosis in China.

Methods: The medical records of 1,582 patients diagnosed with liver cirrhosis from June 2003 to July 2013 at Daping Hospital (Chongqing, China) were retrospectively reviewed through a computer-generated search.

Results: Serum hepatitis B virus surface antigen was present in 1,083 (68.5%) patients, and hepatitis B was found to be the only etiological factor in 938 (59.3%) of all patients. Obesity, diabetes mellitus, and arterial hypertension were observed in 229 (14.5%), 159 (10.1%), and 129 (8.2%) patients, respectively. From 2012-2013, the proportion of non-alcoholic steatohepatitis-related liver cirrhosis increased to 3.2%, whereas the average proportion of non-alcoholic steatohepatitis-related liver cirrhosis in the previous ten years was 1.9%. The incidence of hepatocellular carcinoma was much higher in males than in females (6.3% vs. 3.7%, respectively, p=0.036). Obesity and diabetes mellitus did not significantly increase the incidence of hepatocellular carcinoma in the whole cirrhotic group. The presence of hepatitis B virus was the only risk factor for hepatocellular carcinoma in cirrhotic patients (p<0.001).

Conclusions: Although hepatitis B virus remains the main etiology of liver cirrhosis in China, steatohepatitis-related liver cirrhosis is increasing in frequency. Hepatitis B virus was the sole significant risk factor for hepatocellular carcinoma in the whole cirrhotic group in the present study, in contrast to obesity and diabetes mellitus, for which only a trend of increased hepatocellular carcinoma was found.

Citing Articles

Association Between Quality of Life Defined by EuroQol Group 5 Dimension and Composite Inferior Outcome Among Inpatients with Cirrhosis.

Hui Y, Wang H, Guo G, Yang W, Zhang X, Yang J Clin Interv Aging. 2024; 19:551-560.

PMID: 38528882 PMC: 10962662. DOI: 10.2147/CIA.S444842.

Increasing Prevalence and High Survival Rate of Liver Transplanted Patients with NASH and PSC Cirrhosis.

Khajehahmadi Z, Nikeghbalian S, Roshanaei G, Mohagheghi S Arch Iran Med. 2024; 27(1):23-29.

PMID: 38431957 PMC: 10915929. DOI: 10.34172/aim.2024.04.

Study of liver cirrhosis over twenty consecutive years in adults in Southern China.

Wang X, Luo J, Wu X, Zhang Q, Wu B World J Hepatol. 2024; 15(12):1294-1306.

PMID: 38223413 PMC: 10784809. DOI: 10.4254/wjh.v15.i12.1294.

Global epidemiology of cirrhosis - aetiology, trends and predictions.

Huang D, Terrault N, Tacke F, Gluud L, Arrese M, Bugianesi E Nat Rev Gastroenterol Hepatol. 2023; 20(6):388-398.

PMID: 36977794 PMC: 10043867. DOI: 10.1038/s41575-023-00759-2.

Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.

Li L, Si Y, Cheng M, Lang L, Li A, Liu B Exp Ther Med. 2022; 24(4):633.

PMID: 36160909 PMC: 9468850. DOI: 10.3892/etm.2022.11570.

References

Chen C, Chen J, Wang J, Chang K, Tseng P, Kee K . Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan. Kaohsiung J Med Sci. 2013; 29(8):451-9. DOI: 10.1016/j.kjms.2012.12.006. View

Huang P, Zhu L, Zhai X, Zhu Y, Yue M, Su J . Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiol Infect. 2015; 143(13):2827-36. PMC: 9151013. DOI: 10.1017/S0950268814003719. View

Chen C . Overview of obesity in Mainland China. Obes Rev. 2008; 9 Suppl 1:14-21. DOI: 10.1111/j.1467-789X.2007.00433.x. View

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F . Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27(47):6550-7. DOI: 10.1016/j.vaccine.2009.08.048. View

Reynolds K, Gu D, Whelton P, Wu X, Duan X, Mo J . Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring). 2007; 15(1):10-8. DOI: 10.1038/oby.2007.527. View

Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao Y . Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011; 21(6):401-16. PMC: 3899457. DOI: 10.2188/jea.je20100190. View

Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M . Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2009; 45(1):86-94. DOI: 10.1007/s00535-009-0128-5. View

Caldwell S, Crespo D, Kang H, Al-Osaimi A . Obesity and hepatocellular carcinoma. Gastroenterology. 2004; 127(5 Suppl 1):S97-103. DOI: 10.1053/j.gastro.2004.09.021. View

Berentzen T, Gamborg M, Holst C, Sorensen T, Baker J . Body mass index in childhood and adult risk of primary liver cancer. J Hepatol. 2013; 60(2):325-30. DOI: 10.1016/j.jhep.2013.09.015. View

10.

Fan J, Farrell G . Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2008; 50(1):204-10. DOI: 10.1016/j.jhep.2008.10.010. View

11.

Corey K, Kaplan L . Obesity and liver disease: the epidemic of the twenty-first century. Clin Liver Dis. 2013; 18(1):1-18. DOI: 10.1016/j.cld.2013.09.019. View

12.

Ascha M, Hanouneh I, Lopez R, Tamimi T, Feldstein A, Zein N . The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51(6):1972-8. DOI: 10.1002/hep.23527. View

13.

Shimizu I, Ito S . Protection of estrogens against the progression of chronic liver disease. Hepatol Res. 2007; 37(4):239-47. DOI: 10.1111/j.1872-034X.2007.00032.x. View

14.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F . Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009; 200(1):39-47. DOI: 10.1086/599332. View

15.

Yim H, Lok A . Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006; 43(2 Suppl 1):S173-81. DOI: 10.1002/hep.20956. View

16.

Mena A, Pedreira J, Castro A, Lopez S, Vazquez P, Poveda E . Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers. J Gastroenterol Hepatol. 2013; 29(1):173-8. DOI: 10.1111/jgh.12432. View

17.

Karagozian R, Derdak Z, Baffy G . Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism. 2014; 63(5):607-17. DOI: 10.1016/j.metabol.2014.01.011. View

18.

Perz J, Armstrong G, Farrington L, Hutin Y, Bell B . The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4):529-38. DOI: 10.1016/j.jhep.2006.05.013. View

19.

Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T . Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol. 2012; 18(3):237-43. PMC: 3261540. DOI: 10.3748/wjg.v18.i3.237. View

20.

Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T . Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol. 2009; 44(12):1190-4. DOI: 10.1007/s00535-009-0112-0. View